Tripling Growth Year-Over-Year, Certify Emerges as the Go-To Partner for Health Plans NEW YORK, June 26, 2025 /PRNewswire/ -- Certify,...
Physician and Republican leader voices concern over rising crime and strained social infrastructure in the city Image by Dr. Anosh...
Guidance also outlines metabolic evaluation – like Baylor Genetics’ unique Global MAPS® untargeted metabolite screen – as second-tier testHOUSTON, June...
Aeroflow’s new philanthropic giving initiative includes bold financial and volunteer commitments to healthcare, housing, and education to uplift underserved populationsASHEVILLE,...
CUPERTINO, Calif., June 26, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage...
CONCORD, Ontario, June 26, 2025 (GLOBE NEWSWIRE) -- Ultrack Systems Inc. (OTC: MJLB) is excited to announce the official launch...
Important Study Shows Vivos Technology to be a Safe and Highly Effective, Non-Surgical Alternative to Surgical Removal of Tonsils and...
Brings 20+ years of revenue growth leadership in laboratory testing, clinical diagnostics and global expansionLed successful organizational turnarounds and growth...
PRESS RELEASEParis, 26th June 2025 Ramsay Générale de Santé Board of Directors appoints Natalie Davis as Chairman of the Board...
New program covers employees' cost of attendance to DPT program to address PT shortage and student debtLOUISVILLE, Ky., June 26,...
ASCEND comprises two dosing regimens of certepetide evaluated in two separate study arms enrolled sequentially Positive signal in progression-free survival...
Recognition highlights EluPro™ Antibiotic-Eluting BioEnvelope’s impact on device protection for cardiac implantable electronic devices (CIEDs) and neurostimulators SILVER SPRING, Md.,...
Certification demonstrates Liviniti's strong commitment to data security and risk managementNatchitoches, Louisiana--(Newsfile Corp. - June 26, 2025) - Liviniti, a...
Calgary, Alberta--(Newsfile Corp. - June 26, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company")...
The American Academy of Dermatology (AAD) provided evidence-based recommendation for the use of ZORYVE® (roflumilast) cream 0.15% in adults with...
UNIONDALE, NY, June 26, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), (the “Company” or “ProPhase”) a next generation...
U.S. commercial rollout of novel diagnostic platform to begin second half 2025 Underserved CNS cancer diagnostic U.S. market opportunity estimated...
Attractive safety profile demonstrated across all dosing cohorts and routes of administration (IV, SC, and IM); all reported adverse events...
First product candidate to demonstrate significant MASH effects and weight loss at 24 weeks Trial met its primary endpoint with...
New Study Provides Insight into the Bioavailability of Medical Cannabis Formulations for Therapeutic TreatmentNEW YORK, June 26, 2025 (GLOBE NEWSWIRE)...